Clinical trialNCT01857596CompletedPhase 1/PHASE2Interventional

Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety

SponsorS1 Biopharma, Inc.Enrollment30Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined)Sexual Interest/Arousal Disorder (DSM-5 Defined)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to investigate whether Lorexys is effective and safe to treat premenopausal women who have lost their sexual desire to a distressing degree.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Molly Katz, MD
Katz and Kade, Inc.
Principal Investigator
clinicaltrials.gov ↗
Robert E Pyke, MD, PhD
Chief Medical Officer, S1 Biopharma, Inc.
Study Director
clinicaltrials.gov ↗
Robert T Segraves, MD, PhD
Levine, Risen & Associates, Inc.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Robert Taylor Segraves, Md, Phd
Beachwood, Ohio, United States
Molly Katz, Md
Cincinnati, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bupropion →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2013
Primary completion: 31 Oct 2014
Completion: 31 Oct 2014
Last update posted: 28 Oct 2014
Registered enrollment: 30
Registry id: NCT01857596

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.